Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Celsion Corp (CLSN)

Celsion Corp (CLSN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 20,206
  • Shares Outstanding, K 37,418
  • Annual Sales, $ 500 K
  • Annual Income, $ -16,850 K
  • 60-Month Beta 2.21
  • Price/Sales 39.34
  • Price/Cash Flow N/A
  • Price/Book 1.01
Trade CLSN with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.65
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/16/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.14
  • Number of Estimates 3
  • High Estimate -0.11
  • Low Estimate -0.19
  • Prior Year -0.10
  • Growth Rate Est. (year over year) -40.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4305 +23.11%
on 11/02/20
0.6490 -18.34%
on 10/26/20
-0.0298 (-5.32%)
since 10/23/20
3-Month
0.4305 +23.11%
on 11/02/20
1.0600 -50.00%
on 08/26/20
-0.5200 (-49.52%)
since 08/25/20
52-Week
0.4305 +23.11%
on 11/02/20
6.5000 -91.85%
on 06/17/20
-0.7800 (-59.54%)
since 11/25/19

Most Recent Stories

More News
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Celsion Corporation of Class Action Lawsuit and Upcoming Deadline - CLSN

Pomerantz LLP announces that a class action lawsuit has been filed against certain officers of Celsion Corporation ("Celsion" or the "Company") (NASDAQ: CLSN). The class action, filed in United States...

CLSN : 0.5300 (-1.85%)
ROSEN, A TRUSTED AND TOP RANKED LAW FIRM, Reminds Celsion Corporation Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - CLSN

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Celsion Corporation (NASDAQ: CLSN) between November 2, 2015 and July 10, 2020, inclusive (the "Class Period"),...

CLSN : 0.5300 (-1.85%)
CLSN: Pawar Law Group Announces a Securities Class Action Lawsuit Against Celsion Corporation; IMPORTANT DEADLINE- CLSN

Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Celsion Corporation (NASDAQ: CLSN) from November 2, 2015 through July 10, 2020, inclusive...

CLSN : 0.5300 (-1.85%)
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Celsion, Citigroup, Raytheon, Intercept Pharmaceuticals and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Celsion Corporation (NASDAQ: CLSN),...

RTN : 116.70 (-0.22%)
CLSN : 0.5300 (-1.85%)
C : 57.06 (unch)
RTX : 73.81 (-0.74%)
ICPT : 37.39 (+2.69%)
ROSEN, A TOP RANKED LAW FIRM, Reminds Celsion Corporation Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - CLSN

, /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Celsion Corporation (NASDAQ: CLSN) between and , inclusive (the "Class Period"), of the important...

CLSN : 0.5300 (-1.85%)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Celsion Corporation of Class Action Lawsuit and Upcoming Deadline - CLSN

Pomerantz LLP announces that a class action lawsuit has been filed against certain officers of Celsion Corporation ("Celsion" or the "Company") (NASDAQ: CLSN). The class action, filed in United States...

CLSN : 0.5300 (-1.85%)
ROSEN, LEADING INVESTOR COUNSEL, Reminds Celsion Corporation Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - CLSN

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Celsion Corporation (NASDAQ: CLSN) between November 2, 2015 and July 10, 2020, inclusive (the "Class Period"),...

CLSN : 0.5300 (-1.85%)
CLSN DEADLINE ALERT: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against Celsion Corporation - CLSN

Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Celsion Corporation (NASDAQ: CLSN) between November 2, 2015 and July 10, 2020, inclusive (the "Class Period")....

CLSN : 0.5300 (-1.85%)
New Strong Sell Stocks for November 19th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.

CLSN : 0.5300 (-1.85%)
EMAN : 1.1300 (+0.89%)
MCY : 46.22 (-0.94%)
FENC : 7.88 (+3.14%)
ALRN : 1.0700 (+1.90%)
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Zosano Pharma, Celsion, Citigroup, and Raytheon and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Zosano Pharma Corporation (NASDAQ:...

ZSAN : 0.5800 (+2.22%)
CLSN : 0.5300 (-1.85%)
C : 57.06 (unch)
RTX : 73.81 (-0.74%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Celsion is dedicated to the development and commercialization of oncology drugs including tumor-targeting treatments using focused heat energy in combination with heat activated drug delivery systems. Celsion has research, license or commercialization agreements with leading institutions such as the...

See More

Key Turning Points

2nd Resistance Point 0.5564
1st Resistance Point 0.5432
Last Price 0.5300
1st Support Level 0.5134
2nd Support Level 0.4968

See More

52-Week High 6.5000
Fibonacci 61.8% 4.1815
Fibonacci 50% 3.4653
Fibonacci 38.2% 2.7490
Last Price 0.5300
52-Week Low 0.4305

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar